Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
Metabolic Syndrome and Related Disorders|March 4, 2015
PCSK9 inhibitors: the next frontier in low-density lipoprotein loweringIshwarlal Jialal, Shailendra B PatelPflugers Archiv : European Journal of Physiology|January 28, 2006
Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterolsStarr E Hazard, Shailendra B PatelJournal of AOAC International|May 6, 2015
The Atherogenicity of Plant Sterols: The Evidence from Genetics to Clinical TrialsOliver Weingärtner, Daniel Teupser, Shailendra B PatelClinical Lipidology|June 22, 2018
Investigating Sitosterolemia to Understand Lipid PhysiologyT Hang Nghiem-Rao, Shailendra B PatelJournal of Lipid Research|November 28, 2012
Dietary xenosterols lead to infertility and loss of abdominal adipose tissue in sterolin-deficient miceCurzio Solca, G Stephen Tint, Shailendra B PatelMetabolism: Clinical and Experimental|July 26, 2014
Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatmentJessica B Altemus, Shailendra B Patel, Ephraim SehayekJournal of Lipid Research|May 6, 2018
ABCG5 and ABCG8: more than a defense against xenosterolsShailendra B Patel, Gregory A Graf, Ryan E TemelGastroenterology|May 16, 2006
Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosisGerald Salen, Thomas Starc, Christine McCrary Sisk, et al.Brain Research. Developmental Brain Research|May 3, 2005
Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promoter-driven DHCR7 transgene expressionHongwei Yu, Andy Wessels, G Stephen Tint, et al.Metabolic Syndrome and Related Disorders|December 10, 2014
Effects of simvastatin and ezetimibe in lowering low-density lipoprotein cholesterol in subjects with type 1 and type 2 diabetes mellitusKevin Ciriacks, Gerard Coly, Shanthi Krishnaswami, et al.Pageof 8